propafenone has been researched along with Paralysis in 1 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alfonsi, E | 1 |
| Merlo, IM | 1 |
| Tonini, M | 1 |
| Ravaglia, S | 1 |
| Brugnoni, R | 1 |
| Gozzini, A | 1 |
| Moglia, A | 1 |
1 other study available for propafenone and Paralysis
| Article | Year |
|---|---|
Efficacy of propafenone in paramyotonia congenita.
Topics: Action Potentials; Adult; Anti-Arrhythmia Agents; DNA Mutational Analysis; Drug Administration Sched | 2007 |